Clinical Remission in Severe T2‐High Asthma in Real Life After Anti‐IgE, Anti‐IL‐5 and Anti‐IL5R: A Potential Role for CRP as a Biomarker

ABSTRACT Background Biotherapies have transformed the management of severe asthma (SA), shifting treatment goals from disease control toward achieving clinical remission. This study aimed to evaluate the effectiveness of biotherapies in inducing remission in severe asthma and to identify baseline pa...

Full description

Bibliographic Details

Published in:	Clinical and Translational Allergy
Main Authors:	Jeanne Vervier, Marie Sabbe, France Louis, Catherine Moermans, Françoise Guissard, Carole Sanchez, Virginie Paulus, Monique Henket, Genevieve Philippe, Casper W. H. Beijnink, Pierre‐Olivier Bridevaux, Florence Schleich, Renaud Louis
Format:	Article
Language:	English
Published:	Wiley 2026-04-01
Subjects:	biologics biomarkers CRP severe asthma
Online Access:	https://doi.org/10.1002/clt2.70164